Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Acta Bio-Medica de l Ateneo Parmense ; 93(4):e2022217, 2022.
Article in English | MEDLINE | ID: covidwho-2026278

ABSTRACT

BACKGROUND AND AIM: During the COVID-19 pandemic in India, an increase in the number of suicides was observed in India. Therefore, the present study aims to explore various factors affecting the mental health of an individual and their consequences. Moreover, it has been attempted to assess the suicidal risk in the population of North India by using the Suicidal Behaviors Questionnaire-Revised (SBQ-R). METHODOLOGY: The young adults from the North Indian population belonging to the age group of 18 to 35 years (24.93+/-4.42 years) have been incorporated into the study. A total of 190 responses (102 males and 88 females) were recorded through online mode. The present questionnaire has incorporated the Suicidal Behaviors Questionnaire-Revised (SBQ-R) and some of the parameters taken from the psychology today online survey. RESULTS: The demographic characteristics of the respondents were described by using frequencies and percentages, means, and standard deviations. Cronbach's alpha, Kaiser-Meyer-Olkin (KMO), and the Bartlett sphericity were calculated. The mean SBQ-R score was recorded to be 4.62+/-1.5. Further, during the factor analysis with the principal component method, seven factors have explained the 70.797% of the cumulative variance with an eigenvalue of 1. CONCLUSIONS: The SBQ-R assessment revealed a minimal risk of suicidal behavior but the frequency distribution of the parameters taken for the psychological assessment has highlighted that anxiousness or worriedness has a significant impact on the mental health of the population at risk. Therefore, it is recommended that some precautionary measures, such as online mental health services, should be taken by the health ministry to keep the population healthy.

2.
Indian Journal of Nephrology ; 31(2):89-91, 2021.
Article in English | EMBASE | ID: covidwho-1224290

ABSTRACT

In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmission and enhance herd immunity. Immuno-compromised patients should not receive live vaccines as they can cause vaccine-related disease and hence the guidelines suggest that all transplant recipients should receive age-appropriate 'inactivated vaccine' as recommended for general population. Though trials have not been undertaken on transplant recipients, efficacy and safety of COVID-19 vaccine have been scientifically documented for few vaccines among the general population.

3.
Indian Journal of Transplantation ; 15(1):1-3, 2021.
Article in English | Scopus | ID: covidwho-1187091

ABSTRACT

In December 2019 Novel corona virus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID 19 Vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID -19 infection or atleast diminish the severity of the disease. It would also reduce the risk of the continuing transmission and enhance herd immunity. Immuno compromised patients should not receive live vaccines as they can cause vaccine related disease and hence the guidelines suggest that all transplant recipients should receive age appropriate 'inactivated vaccine' as recommended for general population. Though trials have not been undertaken on transplant recipients, efficacy and safety of COVID-19 vaccine have been scientifically documented for few vaccines among the general population. © 2021 Indian Journal of Transplantation ;Published by Wolters Kluwer - Medknow.

SELECTION OF CITATIONS
SEARCH DETAIL